ChoiceSpine’s implants include minimally invasive and orthobiologic products, according to a June 21 news release. ECential Robotics’ platform combines intraoperative 2D and 3D imaging and navigation in a fully-unified single-device system. ECential Robotics’ technology is FDA-cleared, and preclinical evaluation tests have been conducted in the U.S. in 2022.
“This combination of our innovative cultures will allow us to expand our clinical value by fully encompassing the surgical experience,” Steve Ainsworth, PhD, executive vice president of strategy and technology at ChoiceSpine, said in the release. “We believe the eCential Robotics platform, in conjunction with our comprehensive spinal implant and orthobiologics portfolios, will lead the way in advancing spine surgery.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.